Blue Bell Private Wealth Management’s Nabriva Therapeutics plc Ordinary Shares Ireland NBRV Stock Holding History

Blue Bell Private Wealth Management’s Portfolio NBRV Stock Details NBRV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-9	Closed	–	–	932
2022 Q1	$0	Hold	9	–	–	﹤0.01%	970
2021 Q4	$0	Buy	+9	New	+$213	﹤0.01%	871

Other funds holding NBRV

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

ACM

Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

AICPI

ABG Innovation Capital Partners III Central, Hong Kong, Hong Kong $64.5K AUM 1.01% 1-Year Est. Return

Blue Bell Private Wealth Management's NBRV Position: Q2 2022 in Review

Blue Bell Private Wealth Management sold out of Nabriva Therapeutics plc Ordinary Shares Ireland (NBRV) in Q2 2022, closing a stake of 9 shares.

Blue Bell Private Wealth Management first reported a position in NBRV in Q4 2021 and held it in 2 quarters. The position peaked at $0 in Q1 2022. 25 funds tracked by Wall St. Rank hold NBRV as of Q2 2022.

Blue Bell Private Wealth Management reported no remaining Nabriva Therapeutics plc Ordinary Shares Ireland position as of Q2 2022 after selling out during the quarter.
Blue Bell Private Wealth Management sold 9 Nabriva Therapeutics plc Ordinary Shares Ireland shares in Q2 2022.
Blue Bell Private Wealth Management first reported a position in Nabriva Therapeutics plc Ordinary Shares Ireland in Q4 2021 and held it in 2 quarters.
Blue Bell Private Wealth Management's Nabriva Therapeutics plc Ordinary Shares Ireland position peaked at $0 in Q1 2022.
25 funds tracked by Wall St. Rank held Nabriva Therapeutics plc Ordinary Shares Ireland as of Q2 2022.

Based on Blue Bell Private Wealth Management's 13F filing for Q2 2022, filed 2 Aug 2022.